Latest Headlines

31. NephroSant Features QSant, The First Urine Test For Kidney Transplant Rejection, At Biotech Showcase Digital 2022 1/3/2022

    NephroSant, Inc. a biotechnology company dedicated to accelerating the diagnosis of early kidney damage in native and transplanted kidneys, with a mission to significantly improve global kidney health, announced that it will present a company overview at the upcoming Biotech Showcase conference.

32. Faster Than Ever Before: Ultra-Rapid COVID-19 RT-PCR Testing 12/31/2021

    With the arrival of the Omicron variant in the United States, fast and accurate COVID-19 testing is key to provide answers so organizations can take necessary precautions to stay safe.

33. Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST Rapid COVID-19 Antigen Self-Test 12/29/2021

    Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, 2, 3 providing nationwide access to a new at-home or over-the-counter self-test as COVID-19 testing needs continue to grow for individuals, families, and businesses.

34. 1health Helps Organizations Bridge The Testing Supply Gap 12/29/2021

    1health, a nationwide network of clinical laboratories and kit providers, is helping employers overcome testing supply issues with consistent, timely, and competitively priced COVID-19 testing solutions.

35. Baylor Genetics And SRL, Inc. Initiate Clinical Grade Of Whole Exome And Genome Sequencing Technology Transfer 12/29/2021

    Baylor Miraca Genetics Laboratories, LLC (BG), a clinical diagnostics laboratory in the U.S. known for genetic testing and precision medicine, and SRL, Inc., the largest lab for lab testing and its related services (LTS) in Japan, signed a sub-licensing agreement for clinical-grade whole exome sequencing (WES) and whole genome sequencing (WGS) services in order to establish clinical genetic testing at SRL in the future.

36. Quidel Antigen Tests Detect Omicron Variant 12/28/2021

    Quidel Corporation (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, issued the following statement from Douglas Bryant, Quidel’s President and CEO, regarding Quidel’s ongoing efforts to evaluate COVID-19 mutations and confirm that its antigen tests continue to detect COVID-19 variants such as Omicron.

37. Sorrento Announces COVISTIX COVID-19 Virus Rapid Antigen Detection Test Detects The Omicron Variant 12/27/2021

    Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today that initial testing of COVISTIX on recombinant N proteins demonstrated its ability to detect the Omicron variant, in addition to detecting the original SARS-CoV-2 virus and its other major VoCs such as the delta and delta-plus strains.

38. Hologic Launches Panther Trax For High Volume Molecular Testing 12/23/2021

    Hologic announced today that it has completed regulatory filings needed to make Panther Trax available in a number of countries and regions. Launch of Panther Trax represents the latest addition to the Panther Scalable Solutions (PSS) portfolio of products, offering the ultimate in lab automation by physically linking multiple Panther instruments together into a single, powerful workcell that allows labs to increase testing volumes without increasing staff.

39. Labcorp Strengthens Oncology Leadership Position With The Addition Of Personal Genome Diagnostics, A Provider Of Comprehensive Liquid Biopsy And Tissue-Based Genomic Products And Services 12/23/2021

    Labcorp a leading global life sciences company, today announced that it has entered into a definitive agreement to acquire Personal Genome Diagnostics Inc. (PGDx), a leader in cancer genomics with a portfolio of comprehensive liquid biopsy and tissue-based products.

40. Carolina Liquid Chemistries Corp. Partners With Alltests Clinical Solutions, LLC To Distribute ACON Laboratories Flowflex™ COVID-19 Antigen Home Test 12/23/2021

    Veteran owned Carolina Liquid Chemistries Corp. (CLC) announced it has teamed up with New Jersey-based Alltests Clinical Solutions, LLC (Alltests), an authorized distributor, to distribute the Flowflex COVID-19 Antigen Home Test.